Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Jun 2021 for Checkmate Pharmaceuticals, Inc., €37k. Read the official filing
Filing timeline
BuySaleArthur M. Krieg
Insider track record
Disclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Arthur M. Krieg: trading record in brief
Arthur M. Krieg (senior executive) discloses dealings in Checkmate Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 18 May 2021 to 18 June 2021, the count stands at 4 filings.
The open-market record is one-sided, with 3 purchases worth €198k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Half of the purchases are above €37k and half below. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.
On 21 June 2021 came the latest disclosure, an open-market purchase for €37k in Checkmate Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Arthur M. Krieg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
7,224 shares@ US$6.0418.5% of flowCommon StockSEC:0000899243-21-024984:0
Canonical exit: 16 Sept 2021 (T+90)
3,578 shares@ US$6.189.3% of flowCommon StockSEC:0000899243-21-024427:0
Canonical exit: 14 Sept 2021 (T+90)
68,457 shares0Common StockSEC:0000899243-21-021392:0
25,001 shares@ US$6.9772.1% of flowCommon StockSEC:0000899243-21-019922:0
Canonical exit: 16 Aug 2021 (T+90)
4 of 4 declarations
